Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Oncogene ; 25(39): 5446-61, 2006 Aug 31.
Artigo em Inglês | MEDLINE | ID: mdl-16607277

RESUMO

Altered expression of GATA factors was found and proposed as the underlying mechanism for dedifferentiation in ovarian carcinogenesis. In particular, GATA6 is lost or excluded from the nucleus in 85% of ovarian tumors and GATA4 expression is absent in majority of ovarian cancer cell lines. Here, we evaluated their DNA and histone epigenetic modifications in five ovarian epithelial and carcinoma cell lines (human 'immortalized' ovarian surface epithelium (HIO)-117, HIO-114, A2780, SKOV3 and ES2). GATA4 and GATA6 gene silencing was found to correlate with hypoacetylation of histones H3 and H4 and loss of histone H3/lysine K4 tri-methylation at their promoters in all lines. Conversely, histone H3/lysine K9 di-methylation and HP1gamma association were not observed, excluding reorganization of GATA genes into heterochromatic structures. The histone deacetylase inhibitor trichostatin A, but not the DNA methylation inhibitor 5'-aza-2'-deoxycytidine, re-established the expression of GATA4 and/or GATA6 in A2780 and HIO-114 cells, correlating with increased histone H3 and H4 acetylation, histone H3 lysine K4 methylation and DNase I sensitivity at the promoters. Therefore, altered histone modification of the promoter loci is one mechanism responsible for the silencing of GATA transcription factors and the subsequent loss of a target gene, the tumor suppressor Disabled-2, in ovarian carcinogenesis.


Assuntos
Fatores de Transcrição GATA/genética , Histonas/metabolismo , Neoplasias Ovarianas/genética , Acetilação , Proteínas Adaptadoras de Transdução de Sinal/genética , Proteínas Reguladoras de Apoptose , Carcinoma , Linhagem Celular Tumoral , Feminino , Fator de Transcrição GATA4/genética , Fator de Transcrição GATA6/genética , Inativação Gênica , Genes Supressores de Tumor , Heterocromatina/genética , Humanos , Lisina , Metilação , Proteínas Supressoras de Tumor
2.
Cardiovasc Drugs Ther ; 12(4): 375-81, 1998 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9825183

RESUMO

A clinically available mixture of hydroxyethylrutosides (HR) was examined as a protector against endothelial cell activation by hypoxia in perfused human umbilical vein. The results showed that 500 micrograms/mL HR totally inhibited the adherence of human unstimulated neutrophils to the endothelium of umbilical vein incubated in hypoxic conditions. This inhibition was confirmed by a morphological study performed by scanning electron microscopy. In addition, neutrophils adherent to the hypoxic umbilical vein endothelium became activated, as evidence by the increased release of superoxide anions and synthesis of leukotriene B4. These processes could also be inhibited by HR. In conclusion, the results of this study suggest that the improvement in venous insufficiency observed clinically with HR could, in part, be the result of their ability to inhibit the recruitment and activation of neutrophils by endothelium activated during blood stasis.


Assuntos
Adesão Celular/efeitos dos fármacos , Endotélio Vascular/efeitos dos fármacos , Flavonoides/farmacologia , Hidroxietilrutosídeo/farmacologia , Ativação de Neutrófilo/efeitos dos fármacos , Veias Umbilicais/efeitos dos fármacos , Humanos , Hipóxia/complicações , Técnicas Imunoenzimáticas , Teste de Inibição de Aderência Leucocítica , Leucotrieno B4/biossíntese , Microscopia Eletrônica de Varredura , Neutrófilos/patologia , Superóxidos/metabolismo
3.
Eur J Pharmacol ; 345(1): 89-95, 1998 Mar 12.
Artigo em Inglês | MEDLINE | ID: mdl-9593599

RESUMO

Although venous stasis due to blood stagnation in lower limbs has been recognised as an important etiological factor for the development of varicose veins, the mechanism linking this ischemic situation to the modifications of the venous wall in varicose veins is still unclear. There is evidence that the activation of the endothelium during blood stasis and its subsequent cascade of interactions with other cell types could alter the structure of the vein wall and could possibly be at the origin of the disease. While phlebotonic drugs are often used to improve symptoms in chronic venous insufficiency, their precise mechanism of action is not well understood. We now tested aescine (Reparil i.v. form) in an ex vivo model which mimics this situation, i.e., perfused human umbilical vein exposed to hypoxic conditions. To study the effect of aescine on neutrophil activation and adhesion to the endothelium, human umbilical veins were incubated under hypoxic conditions with or without aescine and the interactions between the endothelium and neutrophil-like cells, HL60, were investigated. We observed that a large number of HL60 became adherent to the endothelium of veins after 2 h hypoxia and that these adherent HL60 were activated: they released high amounts of superoxide anion and of leukotriene B4. Aescine (250 ng/ml or 0.22 microM) was shown to markedly inhibit HL60 adherence to hypoxic endothelium. By decreasing the number of adherent HL60, aescine also decreased the subsequent production of superoxide anion and of leukotriene B4. Scanning electron microscopy confirmed the increased HL60 adherence to the endothelium, as well as the inhibitory effect of aescine. These results support results of in vitro studies on isolated endothelial cells in which aescine was shown to inhibit the hypoxia-induced activation of endothelial cells and the subsequent increased adherence of neutrophils. In vivo, the activated and infiltrated leukocytes release free radicals, chemotactic molecules such as leukotriene B4 and proteases which then can degrade the extracellular matrix. These processes could contribute to alterations of the venous wall similar to those observed in varicose veins. By maintaining an intact endothelium during in vivo blood stasis in the lower limbs and preventing neutrophil recruitment, adherence and activation, aescine could prevent the resulting alterations of the venous wall. These results could explain at least in part the potential benefit of the drug in the prevention of venous insufficiency.


Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Hipóxia Celular/efeitos dos fármacos , Endotélio Vascular/efeitos dos fármacos , Escina/farmacologia , Neutrófilos/efeitos dos fármacos , Salicilatos/farmacologia , Adesão Celular/efeitos dos fármacos , Hipóxia Celular/fisiologia , Linhagem Celular , Combinação de Medicamentos , Endotélio Vascular/ultraestrutura , Humanos , Leucotrieno B4/metabolismo , Microscopia Eletrônica de Varredura , Neutrófilos/ultraestrutura , Superóxidos/metabolismo , Veias Umbilicais/citologia , Veias Umbilicais/efeitos dos fármacos
4.
J Invest Dermatol ; 102(1): 111-7, 1994 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-8288902

RESUMO

Dispase has been utilized to produce basal detachment of the epidermis of human skin biopsies and to study the consequences induced afterwards during incubations of the detached tissue. Spatial reorganization of the epidermis is observed under these conditions and is characterized by disappearance of the typical basal keratinocyte layer. Immunofluorescent labelings reveal upward migration of several cells exhibiting the basal phenotype between suprabasal differentiating keratinocytes and demonstrate progressive intracellular expression of hemidesmosomal components: the integrin alpha 6 beta 4 and two plaque components, the 230-kDa bullous pemphigoid antigen and HD1, a 500-kDa protein. Using electron microscopy and immunogold techniques, we demonstrate that the hemidesmosome-containing basal membrane domains enter the cell cytoplasm after detachment of the epidermal tissue. Partial recycling of internalized hemidesmosomal components is also suggested. Our findings illustrate the processing of released hemidesmosomes in detached basal keratinocytes and suggest some heterogeneity between basal cells migrating towards a suprabasal position and those remaining in the basal layer. These results suggest that the dispase-detached epidermis is a self-remodeling tissue in which basal keratinocytes' and tissue's polarities observed in the anchored epidermis are progressively changing.


Assuntos
Antígenos de Superfície/metabolismo , Desmossomos/metabolismo , Endopeptidases/farmacologia , Epiderme/metabolismo , Integrinas/metabolismo , Adulto , Antígenos de Superfície/análise , Membrana Basal/metabolismo , Membrana Basal/fisiologia , Membrana Basal/ultraestrutura , Comunicação Celular/fisiologia , Movimento Celular/fisiologia , Células Cultivadas , Citoplasma/química , Citoplasma/metabolismo , Citoplasma/fisiologia , Desmossomos/química , Desmossomos/ultraestrutura , Células Epidérmicas , Epiderme/química , Imunofluorescência , Humanos , Integrina alfa6beta4 , Integrinas/análise , Microscopia Eletrônica , Fenótipo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...